工程化Mycoplasma pneumoniae针对双种细菌生物膜:一种新的抗感染策略
Rocco Mazzolini1,2, Victoria Garrido3, Andromeda-Celeste Gomez4,5
1Pulmobiotics Ltd, Barcelona, Spain. rocco.mazzolini@uab.cat.
NPJ biofilms and microbiomes
|November 17, 2025
概括
工程化Mycoplasma pneumoniae在体外和体内有效地破坏有害的细菌生物膜. 这种新的治疗策略为打击抗菌素耐药性和慢性感染提供了一个有希望的方法.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 传染性疾病 传染性疾病
背景情况:
- 抗微生物耐药性 (AMR) 是一个关键的全球卫生问题,多微生物生物膜加剧了慢性感染的治疗失败.
- 黄金葡萄球菌和Pseudomonas aeruginosa生物膜在呼吸器相关的肺炎和囊性纤维化等疾病中很普遍.
研究的目的:
- 设计一个减弱的Mycoplasma pneumoniae菌株,以产生生物膜降解酶.
- 评估工程M.肺炎菌对S. aureus和P. aeruginosa生物膜的疗效.
- 探索Galleria mellonella幼虫作为生物膜干预研究的体内模型的潜力.
主要方法:
- 微粒体肺炎CV8_HAD的工程,以分泌PelAh,PslGh,A1-II'和B.
- 在体外测试对单个和混合物种生物膜的S. aureus和P. aeruginosa.
- 在S. aureus生物膜和G. mellonella幼虫混合感染的小鼠模型中的体内疗效评估.
主要成果:
- 改造的M. pneumoniae在实验室中证明了对S. aureus和P. aeruginosa生物膜的强有力的破坏.
- 显著的体内疗效被观察到对S. aureus生物膜在小鼠.
- 在G. mellonella幼虫中成功治疗混合感染,验证了模型.
结论:
- 改造的M. pneumoniae代表了对抗微生物生物膜的可行的治疗候选者.
- 该研究验证了G. mellonella幼虫作为评估生物膜向干预措施的合适替代模型.
- 这种方法有望解决具有挑战性的慢性呼吸道感染和抗菌素耐药性的问题.
相关概念视频
01:29Biofilms
1.1K
Biofilms are complex communities of microorganisms encased in a self-produced extracellular polysaccharide matrix attached to surfaces. These microbial consortia can include single or multiple species, providing enhanced survival benefits by forming organized, multilayered structures.The formation of biofilms occurs through four key stages: attachment, colonization, development, and dispersal.During attachment, free-swimming planktonic cells adhere to a surface, often facilitated by...
1.1K
01:28Gene Regulation in Microbial Communities: Quorum Sensing
479
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
479